MuCell Extrusion has licensed Dow Chemical’s patent portfolio for thin foamed films.
The deal adds to the two companies existing collaboration relationship.
The companies said in a news release that the new agreement “not only eliminates existing confusion among potential customers as to patent and licensing obligations, but it also provides a clear demarcation of responsibilities for support of these foaming technologies.”
Midland, Mich.-based Dow will offer resins specially formulated to optimize foaming results, while Woburn-based MuCell will provide technology transfer equipment and technical support.
This deal follows a similar agreement announced 1 March for MuCell Extrusion to exclusively license Dow’s patent family on flat sheet resin technology.
No comments:
Post a Comment